Tag: PRMT5 inhibitor program
Victorian research centre inks major pharma deal
The Australian Cancer Therapeutics Cooperative Research Centre (CTx), their UK based research and commercialisation partner Cancer Research Technology (CRT) and global pharmaceutical giant MSD...
Featured Article
Good Design Australia opens entries for 2026 awards
For more than six decades, Good Design Australia has celebrated the power of design to shape innovation, industry, and everyday life. Its flagship program, the Australian Good Design Awards, recognises projects that show how thoughtful design can enhance products, services, systems, and communities.
